Venture Capital Archives - Page 75 of 99

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

May 7, 2025

THIS WEEK'S STORIES

Ansa Biotechnologies Launches Early Access Program for 50 kb Synthetic DNA, Setting New Benchmark in Genomic Research

May 6, 2025

Twist Bioscience Spins Out DNA Data Storage Unit as Independent Company, Launches Atlas with $155M Backing

May 5, 2025

Novellia Wins 2025 MedTech Breakthrough Award for AI Innovation in Health Record Integration

May 8, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Jaanuu Acquired by VentureOn Management in Strategic Asset Sale

HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Therapies for Chronic and Age-Related Diseases

TSOLife Raises $43 Million Series B to Advance AI-Driven Innovation in Senior Living Communities

GeneDx Completes Acquisition of Fabric Genomics to Expand Global Genomic Medicine Capabilities

Koala Health Raises $20 Million in Series B to Expand Pet Medication Delivery Platform

Most Read

GSK and Lifetime Team Up to Raise Awareness of Meningitis Through New Original Movie

What’s a fair price for a drug that’s never developed?

QuantHealth Launches First Clinical AI Foundation Model for Life Sciences Industry

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

EDITOR PICKS

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

THIS WEEK'S STORIES

Ansa Biotechnologies Launches Early Access Program for 50 kb Synthetic DNA, Setting New Benchmark in Genomic Research

Twist Bioscience Spins Out DNA Data Storage Unit as Independent Company, Launches Atlas with $155M Backing

Novellia Wins 2025 MedTech Breakthrough Award for AI Innovation in Health Record Integration

POPULAR CATEGORY

ABOUT US

FOLLOW US